🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Status
Terminated
Location
The Queen Elizabeth Hospital
Start Date
2025-06-16
Trial ID
NCT06692959
Treatments Being Tested
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
Part I: 12 subjects will receive an open-label 500 µl subcutaneous injecti...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-11-27
Trial ID
NCT04546841
Treatments Being Tested
RATIONALE: Vaccines made from a peptide may help the body build an effectiv...
Status
Unknown
Location
Mayo Clinic Scottsdale
Start Date
2005-05
Trial ID
NCT00454168
Treatments Being Tested
The purpose of this study is to evaluate a new investigational cancer vacci...
Status
Completed
Location
Highlands Oncology Group
Start Date
2015-01-14
Trial ID
NCT02229084
Treatments Being Tested
The overarching purpose of this study is to evaluate the clinical efficacy ...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2015-10
Trial ID
NCT02264236
Treatments Being Tested
The PerVision trial utilizes an approach of a patient-individual cancer vac...
Status
Recruiting
Location
Pediatrics III, West German Cancer Centre, University Hospital
Start Date
2023-09-19
Trial ID
NCT06094101
Treatments Being Tested
To determine the safety and immunogenicity profile of two (2) different dos...
Status
Completed
Location
Rush University Medical Center
Start Date
2010-03
Trial ID
NCT01095848